Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

Portable solution for prehospital diagnosis of stroke in the ultra-acute phase

Objective

This project will change the clinical landscape for the early and differential diagnosis of stroke – moving the diagnosis to the primary ambulance intervention site with the use of Strokefinder – an innovative medical diagnostic device based on microwave technology. Today, stroke is responsible for 405,000 deaths (9%) in men and 583,000 (13%) deaths in women each year. The projections indicate that between 2015 and 2035, overall there will be a 34% increase in total number of stroke events in the EU. Most strokes (87%) are ischaemic (caused by thrombosis or embolisms) and the rest (13%) are haemorrhagic (caused mainly by rupture of blood vessel or aneurysm). The complications of ischaemic strokes may be limited by early thrombolytic therapy (treatment to dissolve blood clots). However, while 20-30% of patients arriving at specialised stroke centres may receive thrombolytic therapy, only 3-4% of the patient population are given such treatment, mainly due to long lead times in transport to and from the diagnostic instruments (CT-scans). A haemorrhagic stroke (bleeding) excludes thrombolysis therapy until a proper diagnosis is performed. Medfield Diagnostics has developed a portable, more affordable and easy-to- use diagnostic device for this clinical dilemma. The device utilizes changes in the electromagnetic properties of the brain as a biomarker to exclude haemorrhagic stroke. After having provided proof-of- principle in smaller clinical trials and developed a robust prototype, the objective of the proposed project is to develop a business plan that will guide a large-scale prospective clinical trial to validate the device and optimize the go-to-market strategy. The goal is to make early stroke diagnostic and more effective personalized treatment accessible to a much wider population of patients across the EU.

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

SME-1 - SME instrument phase 1

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) H2020-EIC-SMEInst-2018-2020

See all projects funded under this call

Coordinator

MEDFIELD DIAGNOSTICS AKTIEBOLAG
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 50 000,00
Address
MEDICINAREGATAN 8B
41390 GOTEBORG
Sweden

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Södra Sverige Västsverige Västra Götalands län
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

€ 71 429,00
My booklet 0 0